SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Summary

The primary purpose of this study is to determine whether SPD489 low dose range (40, 80, or 100mg) and high dose range (120, 140, or 160mg) are effective in the treatment of Negative Symptoms.

Timeline

Start

2013-02-01

Primary completion

2013-04-01

Completion

2013-04-01

Outcome

Outcome not reported

Stopped (Business): “Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized”

Drugs

Indications